Medical Condition News

RSS

Health Media Network, Digital Blue Dog partner to create Oncology point-of-care network in the U.S.

Connecticut-based Health Media Network and Florida-based Digital Blue Dog have signed an agreement to exclusively represent DBD's Oncology Network, creating the largest Oncology specific and patient-centric point-of-care network in the U.S.

4 Dec 2013

Novel battery jolts dangerously misbehaving heart back to normal rhythm

The engineering feat that enables a device to jolt a dangerously misbehaving heart back to its normal rhythm and save millions of lives is featured in a new video from the popular Prized Science series from the American Chemical Society (ACS).

4 Dec 2013

Researchers analyze protective effects of mild hypothermia on CNS injuries

There are few data on the effectiveness and mechanism underlying mild hypothermia in the treatment of central nervous system injuries. Therefore, there is a need to investigate the potentially beneficial effects of mild hypothermia on central nervous system injuries.

4 Dec 2013

Direct radiographic imaging reveals negative impact of adiposity in older men and women

Researchers at the National Institute for Aging are working to improve understanding about obesity and cancer. A study, published today in the journal Applied Physiology, Nutrition, and Metabolism, is the first to use direct radiographic imaging of adipose tissue rather than estimates like body mass index (BMI) or waist circumference, and focuses on the relationship between obesity and cancer risk in aging populations. Findings emphasize the negative impact of adiposity on long term health particularly for older men and women.

4 Dec 2013

Sympathetic skin response test assesses autonomic nerve functions in patients with spinal cord injury

Neurological functions following spinal cord injury have generally been assessed using the American Spinal Injury Association (ASIA) impairment scale.

4 Dec 2013

Philanthropist pledges $5M to fund new endowed chair in Alzheimer's disease research at Keck School

Los Angeles residents Selim Zilkha and Mary Hayley are raising the stakes in the fight against Alzheimer's disease, the only cause of death among the top 10 in the United States that cannot currently be prevented, cured or slowed.

4 Dec 2013

Study sheds new light on neuropsychiatric disorders

Trauma can scar people so indelibly that their children are affected. History provides examples of generations traumatized by war and starvation, whose children experience altered physiology.

4 Dec 2013

"Appearance exposure" on Internet linked to body image disturbance among adolescent girls

"Appearance exposure" on the Internet has been linked to body image disturbance among adolescent girls. A new study that links specific Facebook activities, but not overall Facebook use to body dissatisfaction and a drive for thinness in teen girls is published in Cyberpsychology, Behavior, and Social Networking, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

4 Dec 2013

Western University research points to promising avenue for PTSD treatment

Pioneering research conducted at Western University (London, Canada) points to a promising avenue for the treatment of post-traumatic stress disorder: utilising neurofeedback training to alter the plasticity of brain networks linked to the condition.

4 Dec 2013

Missing inhibitory connection in brain can trigger social phobias

Fear, at the right level, can increase alertness and protect against dangers. Disproportionate fear, on the other hand, can disrupt the sensory perception, be disabling, reduce happiness and therefore become a danger in itself.

4 Dec 2013

Combining neuroimaging and neuropsychology improves detection of Alzheimer's disease

By combining brain imaging analysis with a neuropsychological assessment, Sylvie Belleville achieved remarkable sensitivity and specificity. The level of accuracy of this classification system is the major breakthrough of the study. "When used individually, neuroimaging and neuropsychology are effective but only up to a certain point. It is when combining and analyzing the results from both methods that we could achieve such an exceptional level of accuracy," explained Sylvie Belleville.

4 Dec 2013

VolitionRx's two-assay test can detect 85% of colorectal cancer, more than 50% of precancerous polyps

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today releases new data showing that when combining two of its proprietary NuQ assays into one test, they can achieve 85% detection rates at 85% specificity for colorectal cancer. The data also shows that Volition’s two-assay test can detect more than 50% of precancerous polyps. These new findings come from its ongoing prospective study with CHU Dinant Godinne | UCL Namur Hospital in Belgium.

4 Dec 2013

Researchers take important step towards development of future drugs for brain diseases

A successful joint collaboration between researchers at the Hebrew university of Jerusalem and the startup company TyrNovo may lead to a potential treatment of brain diseases. The researchers found that TyrNovo's novel and unique compound, named NT219, selectively inhibits the process of aging in order to protect the brain from neurodegenerative diseases, without affecting lifespan. This is a first and important step towards the development of future drugs for the treatment of various neurodegenerative maladies.

4 Dec 2013

Scientists explore new ways to tackle obesity

Scientists are attempting to tackle obesity by exploring ways of helping people stay healthy.

4 Dec 2013

18F-FDOPA imaging can help distinguish radiation-induced lesions in patients with brain metastases

Imaging with the molecular imaging tracer 18F-FDOPA can help distinguish radiation-induced lesions from new tumor growth in patients who have been treated with radiation for brain metastases, according to new research published in The Journal of Nuclear Medicine. Using this amino acid tracer, researchers found that physicians could accurately differentiate the two types of lesions 83 percent of the time. Progression-free survival could also be predicted through evaluating the 18F-FDOPA imaging results.

4 Dec 2013

TSRI scientists discover natural mechanism that cells use to protect mitochondria

Scientists at The Scripps Research Institute have discovered a natural mechanism that cells use to protect mitochondria, the tiny but essential "power plants" that provide chemical energy for cells throughout the body. Damage to mitochondria is thought to be a significant factor in common neurodegenerative disorders, cancer and even the aging process. The TSRI researchers' discovery could lead to new methods for protecting mitochondria from such damage, thereby improving human health.

4 Dec 2013

Better understanding of cancer evolution could help in early detection of cancers

A new appreciation of how cancer cells evolve could help scientists design better screening methods to catch cancer before it advances.

4 Dec 2013

MHIF creates scientific program to address gaps in treating valvular heart disease patients

Despite significant medical advances, there continue to be significant gaps in the health care of the growing number of patients with valvular heart disease. In the USA, the total number of people aged 65 years or older with valvular heart disease will grow to approximately 5.2 million by year 2020, and 6.8 million individuals by the year 2030. The Minneapolis Heart Institute Foundation- has created a scientific program, "Valve Summit 2014: The Science and Delivery of Optimal, Multi-Disciplinary Care," to address the ongoing, complex evolution in the clinical management of patients with valvular heart disease. The conference will be held on April 25th and 26th at the Radisson Blu in downtown Minneapolis.

4 Dec 2013

Lucane Pharma, Medunik Canada to offer new therapeutic option for patients suffering from UCD

Medunik Canada, a pharmaceutical company specialized in orphan drugs and Lucane Pharma, a French niche pharmaceutical company, announced the conclusion of an exclusive collaboration agreement.

4 Dec 2013

Finding identifies new mechanism that could contribute to the pathology of ALS

RNA molecules, used by cells to make proteins, are generally thought to be "silent" when stowed in cytoplasmic granules. But a protein mutated in some ALS patients forms granules that permit translation of stored RNAs, according to a study in The Journal of Cell Biology. The finding identifies a new mechanism that could contribute to the pathology of the disease.

4 Dec 2013

Medical Condition News

Health Media Network, Digital Blue Dog partner to create Oncology point-of-care network in the U.S.

Novel battery jolts dangerously misbehaving heart back to normal rhythm

Researchers analyze protective effects of mild hypothermia on CNS injuries

Direct radiographic imaging reveals negative impact of adiposity in older men and women

Sympathetic skin response test assesses autonomic nerve functions in patients with spinal cord injury

Philanthropist pledges $5M to fund new endowed chair in Alzheimer's disease research at Keck School

Study sheds new light on neuropsychiatric disorders

"Appearance exposure" on Internet linked to body image disturbance among adolescent girls

Western University research points to promising avenue for PTSD treatment

Missing inhibitory connection in brain can trigger social phobias

Combining neuroimaging and neuropsychology improves detection of Alzheimer's disease

VolitionRx's two-assay test can detect 85% of colorectal cancer, more than 50% of precancerous polyps

Researchers take important step towards development of future drugs for brain diseases

Scientists explore new ways to tackle obesity

18F-FDOPA imaging can help distinguish radiation-induced lesions in patients with brain metastases

TSRI scientists discover natural mechanism that cells use to protect mitochondria

Better understanding of cancer evolution could help in early detection of cancers

MHIF creates scientific program to address gaps in treating valvular heart disease patients

Lucane Pharma, Medunik Canada to offer new therapeutic option for patients suffering from UCD

Finding identifies new mechanism that could contribute to the pathology of ALS

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News